Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial

BACKGROUND: In this phase I/II trial, 5-year physician-assessed toxicity and patient reported quality of life data is reported for patients undergoing moderately hypofractionated intensity modulated radiation therapy (IMRT) for prostate cancer using a simultaneous integrated boost (SIB) and pelvic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricco, Anthony, Mukhopadhyay, Nitai, Deng, Xiaoyan, Holdford, Diane, Skinner, Vicki, Saraiya, Siddharth, Moghanaki, Drew, Anscher, Mitchell S., Chang, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471868/
https://www.ncbi.nlm.nih.gov/pubmed/32974208
http://dx.doi.org/10.3389/fonc.2020.01686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471868/
https://www.ncbi.nlm.nih.gov/pubmed/32974208
http://dx.doi.org/10.3389/fonc.2020.01686

Ejemplares similares